Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2022-02-17 Sale | 2022-02-22 4:19 pm | Karyopharm Therapeutics Inc. | KPTI | Shah Jatin EVP, Chief Medical Officer | 1,306 | $12.12 | $15,833 | 129,450 (Direct) | View |
2022-02-07 Sale | 2022-02-09 5:27 pm | Karyopharm Therapeutics Inc. | KPTI | Shah Jatin EVP, Chief Medical Officer | 1,704 | $9.862 | $16,805 | 130,756 (Direct) | View |
2021-05-07 Purchase | 2021-05-11 08:58 am | Karyopharm Therapeutics Inc. | KPTI | Shah Jatin EVP, Chief Medical Officer | 23,250 | $8.6018 | $199,992 | 131,802 (Direct) | View |
2021-02-18 Sale | 2021-02-22 8:12 pm | Karyopharm Therapeutics Inc. | KPTI | Shah Jatin EVP, Chief Medical Officer | 1,186 | $14.83 | $17,590 | 51,791 (Direct) | View |
2021-02-11 Sale | 2021-02-17 6:48 pm | Karyopharm Therapeutics Inc. | KPTI | Shah Jatin EVP, Chief Medical Officer | 1,748 | $15.52 | $27,127 | 62,677 (Direct) | View |
2020-07-15 Sale | 2020-11-04 8:16 pm | Karyopharm Therapeutics Inc. | KPTI | Shah Jatin EVP, Chief Medical Officer | 589 | $19.46 | $11,462 | 50,466 (Direct) | View |
2020-02-19 Sale | 2020-02-21 5:58 pm | Karyopharm Therapeutics Inc. | KPTI | Shah Jatin EVP, Chief Medical Officer | 1,375 | $16.48 | $22,663 | 40,759 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2021-07-12 Tax Withholding | 2021-07-13 6:21 pm | N/A N/A | Karyopharm Therapeutics Inc. | KPTI | Shah Jatin EVP, Chief Medical Officer | 665 | $9.73 | 131,137 (Direct) | View |
2021-02-25 Option Award | 2021-03-01 8:17 pm | N/A 2031-02-24 | Karyopharm Therapeutics Inc. | KPTI | Shah Jatin EVP, Chief Medical Officer | 81,981 | $0 | 167,659 (Direct) | View |
2021-02-15 Exercise | 2021-02-17 6:48 pm | N/A N/A | Karyopharm Therapeutics Inc. | KPTI | Shah Jatin EVP, Chief Medical Officer | 4,850 | $0 | 62,677 (Direct) | View |
2021-02-05 Exercise | 2021-02-09 9:56 pm | N/A N/A | Karyopharm Therapeutics Inc. | KPTI | Shah Jatin EVP, Chief Medical Officer | 5,650 | $0 | 66,825 (Direct) | View |
2020-07-11 Exercise | 2020-11-04 8:16 pm | N/A N/A | Karyopharm Therapeutics Inc. | KPTI | Shah Jatin EVP, Chief Medical Officer | 2,413 | $0 | 50,466 (Direct) | View |
2020-02-15 Exercise | 2020-02-19 6:16 pm | N/A N/A | Karyopharm Therapeutics Inc. | KPTI | Shah Jatin EVP, Chief Medical Officer | 4,850 | $0 | 56,684 (Direct) | View |
2020-02-05 Option Award | 2020-02-07 4:20 pm | N/A 2030-02-04 | Karyopharm Therapeutics Inc. | KPTI | Shah Jatin EVP, Chief Medical Officer | 83,200 | $0 | 83,200 (Direct) | View |